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genesis and, particularly, viral carcinogenesis.
On these subjects, the guides for further
reading refer very largely to older literature
of the 1950s and 1960s. Consequently there
are many inaccuracies in the text relating
to the biology of cancer, because the more
recent literature has not been assimilated.
The clinico-pathological sections on specific
cancers are adequate but little more than a
disguised summary of many standard text-
books of pathology. Again the enquiring
student would almost certainly want to be
referred to more recent clinico-pathological
literature than is invariably quoted here in
the guides for further reading.
It is unlikely that this book will become
compulsory reading for British medical
undergraduates, though it may be of help to
young science graduates in the various
fields of cancer research, and nurses and
para-medical workers may also find it a
useful introduction. The reviewer is left
with the feeling that this book is too con-
densed, inaccurate in parts, and already out
of date.
H. BUSH
Biosynthetic Products for Cancer Chemo-
therapy. Vol. 1 G. R. PETTIT (1977) New
York and London: Plenum Press. xii + 215
pp. £12.29.
This is a book written by an acknowledged
expert in the field of naturally occurring
anti-cancer agents. His long association with
the pioneering activities of the National
Cancer Institute teams involved in screening
for anti-tumour agents is clearly evident
in this highly readable and timely publica-
tion. Furthermore, the consistent style and
approach derived from a writer as author
rather than as editor has paid dividends here.
A much appreciated feature of this book
is the careful thought given to the clear
representation of the chemical structures of
155 of the large number of the agents de-
scribed, but, at one ortwo structural formulae
per page, is sometimes a luxurious use of
space. However, the clear cross-referencing
in the text, particularly to the extensive
reference list is very welcome. Throughout,
synonyms and drug code names are included,
as well as limited dosage information in
many cases. The index is good and provides
a rapid means of identifying the natural
product.
The book is grouped essentially according
to chemical structures. The first chapter,
however, reviews the success of modern
chemotherapy of cancer both in single and
combination drug-treatment modes. Al-
though some reference is made to the carcino-
genic action of some of the chemicals in the
environment, possible later cancers after
successful combination regimes, such as
MOPP treatment of Hodgkin's disease, are
not referred to.
The second chapter is a historical intro-
duction to the use of naturally occurring
substances as anti-neoplastic agents, making
special reference to the current interest in
natural products as anti-tumour agents in
Western countries, as well as in the People's
Republic of China. Justifiable reference is
also made to the valuable contributions to
the literature of anti-cancer plant products
by Jonathan Hartwell in a series of detailed
historical listings which he published from
1950 to 1971. From the mid-60s, extracts of
arthropods and marine organisms have also
been included in the survey, some 10 0 of
which have shown anti-tumour activity.
Three chapters separately consider higher-
plant terpenoids, steroids, and alkaloids
(and associated nitrogenous products). A
chapter includes the products of fungi and
a few bacteria, which show an astonishing
variety of chemical structures with anti-
tumour activity, many of which are very
complex, but nevertheless illustrated in full.
The final chapter deals with the increasingly
interesting, chemically simpler, groups of
agents being isolated from marine organisms.
A highly commendable feature of the whole
book is the anecdotal style of writing,
suggesting a very broad in-depth fascination
with both the historical and geographical
associations of his subject. His careful
recognition of the pioneering work of other
groups is maintained throughout. One is
left wondering how the discovery of anti-
tumour agents from Asian butterflies' wings,
Taiwan stag beetles and Tahitian sea
anemones were in fact made!
Vol. 2. Eds: G. R. PETTIT and G. M. CRAGG
(1978) New York and London: Plenum
Press. ix + 150 pp. £17 approx.
This second volume is a tabular summary
of all the better-known naturally occurring
anti-cancer and cytotoxic substances appear-BOOK REVIEWS 489
ing in the literature. After an introductory
chapter listing 7 schema of isolation of the
natural product, structural formulae w%ith
details such as molecular weight, bioactivity
in different tumour systems, melting point
and the organism of origin, with references,
are given. The existence (but not details)
of spectral data are noted. There is a detailed
index to both the substances themselves
(about 400) and 343 references. There is also
a useful appendix on the Cancer Evaluation
System employed by the U.S. National
Cancer Institute, listing the abbreviations
normally used by them.
These two books are timely and provide
a feast of information for the cancer research
worker and the synthetic chemist, as well as
an information and reference source for those
involved in teaching this otherwise complex
aspect of medical treatment.
B. W. Fox
Antitumour Antibiotics. Eds S. K. CARTER,
H. UMEZAWA, J. DoUROS & Y. SAKURAI.
(Recent Results in Cancer Research, Pt.
63) (1978). Berlin, Neew York: Springer-
Verlag. 303 pp. $42.50 net.
This book is a collection of official papers
delivered to the 3rd Symposium held in San
Francisco in May 1977 as part of the joint
US-Japan Agreement on Cancer Research,
and supported by the Northern California
Cancer Program.
The contribution of this U.S.-Japanese co-
operation to antitumour antibiotic develop-
ment has, without doubt, been of very
considerable benefit to the clinical contain-
ment ofmany human tumours. The historical
background and current developments in this
field are very well summarized in this collec-
tion of papers, and fully justify its publica-
tion. Following a short introduction by S. K.
Carter, the chairman of the U.S. Chemo-
therapy subsection of the agreement, 2
informative review papers by medical repre-
sentatives of Japan and the U.S. summarize
the clinical role of antitumour antibiotics in
their respective countries. This is followed by
a historical review of the National Cancer
Institutes Fermentation Development Pro-
gram by J. Douros, listing the interesting
products obtained. A satisfactory aspect of
this paper is the careful attention paid to the
illustration of full structural formulae and
their respective NSC nomenclature coding,
wNNhich makes it a useful reference source. A
selection of antitumour evaluations of single
and combined treatment in a number of
experimental tumours is briefly listed by
J. M. V7enditti and R. K. Johnson, and in
microbial systems by J. P. N. Rosozza. How-
ever, there are clearly problems as to which
assay system is likely to give the greatest
yield of useful antitumour agents, and the
relative importance of different assay sys-
temns available is discussed by L. J. Hanka
and R. H. Bunge and their respective co-
workers. The development and operation of
the Chemotherapy Fermentation Laboratory
at the Frederick Cancer Research Center is
described in some detail by A. F. Langlykke.
The problem of improving detectioin of
potentially useful antitumour agents con-
tinues to provide a rich forum for discussion,
and a review on the criteria employed by a
distinguished practitioner in this field, A.
Goldin, is useful as reference source of new
analogues and of treatment protocols.
A fascinating paper by H. Umezawa sum-
marizes both the theory and the facts behind
the Japanese programme, with special refer-
ence to bleomycin and its analogues. As with
many other papers from this author, there is
a great deal of description of new and in-
teresting biochemical transformations written
in an interesting and thought-provoking
manner.
Y. Koyama's papers on the current status
of chemotherapy for gastric cancer in Japan
outlines the special oncological problems of
that country, as well as the clinical success of
mitomycin C in its management. A U.S. con-
tribution to this study follows with a paper by
P. S. Schein and co-workers. M. A. Friedman
outlines the role and status of bleomycin in
combination with other agents that are used
in the U.S. Its combination with radiation in
Japan is then discussed by T. Miyamoto and
later by N. Yamanaka and co-w-orkers in
experimental systems. The bleomycin pro-
gramme in Japan has produced over 300
analogues. and detailed studies ofantituinour
properties and toxic side-effects have led to
general conclusions about the origin of these
properties within the structure ofthe molecule
itself. A. Matsuda and co-workers review this
extraordinary piece of co-ordinated research
effort. Radioimmunoassay technology applied
to bleomycin has allowed for more detailed
pharmacokinetic studies in man, reviewed by
S. T. Crooke and co-workers.
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